Context Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€1.14
Target price
31.12.25
€3.00
Performance (%)
54.39%
Price
04.10.24
€1.76
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Context Therapeutics Inc. has seen massive gains of 54.39%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Context Therapeutics Inc. | 8.642% | 8.642% | 47.899% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to BiotechBee what are the pros and cons of Context Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Context Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0